Intellectual Property Archive » July, 2006

Intellectual Property - July, 2006

126 articles

• Chunghwa To Appeal Jury Decision
• University Colors Can Be Trademarked, Judge Rules
• State Attorneys General Reject Revised Plavix Deal
• FTC Probes Mylan Over Provigil Settlements
• Boston Scientific, St. Jude Settle Four Patent Suits
• ImClone Motion Denied In Erbitux Case
• Digene Wins Arbitration Ruling Over HPV License
• Trademark Riff Divides Canadian Gay Groups
• Small Firms Face Royalty Leakage And Portfolio Woes
• Rambus Accepts Slashed Jury Award
• FBI Raids Bristol-Myers Over Plavix Deal
• Samsung Loses Bid For Rambus To Pay Attorney Fees
• Rambus General Counsel Steps Down
• Post-eBay, Expect More Patent Suits, Higher Costs
• Judge OKs SGI Disclosure As Patent Spat Is Resolved
• DOJ Launches Criminal Probe Into Plavix Deal
• Fed. Circuit Upholds Ruling In Cell Phone Dispute
• J&J Unit Takes On Wyeth's Effexor In Patent Suit
• Abbott Wins Antitrust Challenge Over HIV Drug Cocktail
• Kazaa Buries Hatchet With Music Industry For $100M
• Matsushita Brings Patent Suit Against DVD Maker
• Trademark Holders' Rights Over Sublicensees Confirmed
• Suit Over Semiconductor Wafers Settled
• FTC To Use "In Camera" Record In Rambus Case
• Universities, Hospitals Join Patent Litigation Bonanza
• "Rocket Docket" Bill Passes House Markup
• Tyco Sticks Applied Medical With Fresh Patent Suit
• Judge Tosses Patent Case Against Stryker
• Invitrogen Gets Biotech Patent Win In Jury Trial
• Mosaid Swings Back At Micron In DRAM Patent Suit
• Korea Pushes Drug-Pricing Law
• Upsher-Smith, Unigene Sue Apotex After ANDA Filing
• Arbitration Panel Rules In LG Philips' Favor
• USPTO Bottleneck Stalls Nanotech Industry: Report
• Micron Hits Mosaid With Patent Suit
• Eye Care Company Says It's Not Eyeing Rival's Patent
• Sony BMG Hit With Broadened Complaint
• Avis Wins Copyright Suit Against Ex-Employee
• Plavix Ruling From Attorneys General Imminent
• Swiss University Sues Synthes In Pilot Case
• Freedom Wireless, Bcgi Reach $55M Settlement
• PlusFunds Sues Standard & Poor Over Copyright
• Micron Will Pay $30M To Settle Patent Claims
• Discussions On Tax Patents Have Lost Focus
• Erbitux Trial Awaits Judge's Decision
• Judge: No Infringement In Assays Patent Case
• Senators Take Aim At Authorized Generics
• Roche Rallies In Wake Of Enzo Biochem Ruling
• Amgen Criticizes Roche's Anemia Study
• Brinks Hofer Opens Doors In Salt Lake City
• FTC Commissioner Slams Authorized Generics
• Judge Seeks More Info As File-Sharing Feud Heats
• ImClone, Merck Reach Deal Over Erbitux
• Two Months Later, eBay Decision Begins To Trickle Down
• Elan Files Patent Suit Over Breast Cancer Drug
• Group Looks To Overturn Stem Cell Patents
• Court Issues Markman Ruling In Enzo Biochem Case
• Fed. Circuit Affirms University's Grip On Allergy Patent
• Court Finds Non-Infringement In Alaris, ICU Case
• YouTube Lawsuit Emerges In Grokster's Shadow
• Fourth Circuit Rejects Another Authorized Generics Challenge
• Acambis Boosted In Battle For Smallpox Vaccine Market
• Settlement Gets To Heart Of Stent Lawsuit
• Court Upholds Blood Pressure Drug Patent
• Symbol, Intermec Reach Final IP Settlement
• Bio-Rad Settles Lengthy Licensing Dispute
• XM Radio Asks Judge To Throw Out Copyright Suit
• Judge Slashes Rambus Award By $174M
• Jury Denies Baxter's $87M Bid In Dialysis Dispute
• Setback For Australia In Battle Over WiFi Patent
• Dell Targeted In Patent Suit
• NYU Blasts Autodesk With Suit Over Animation Patents
• Keyboard Patents Not Infringed, Federal Circuit Says
• Rulings Highlight Community Patent Rift
• E.U. Patent Law Waiting On French Approval
• Years Later, Lawyer's Error Haunts Inventor
• In Blow To Ivax, Judge Upholds Lexapro Patent
• Tax Patents: Ball Is In Your Court, PTO Tells Congress
• Law Firm Profile: Banner & Witcoff Ltd.
• New Study Supports Biotech Fears Over USPTO Changes
• Intel Lashes Out Against AmberWave's Chip Patent
• Wiped Out By Verdict, Train Maker Begs For Time
• Apple Gives In To Bloggers In Trade Secrets Case
• DLA Piper Pulls In New Patent Attorney
• Generic Drug Settlement Prompts More FTC Scrutiny
• Da Vinci Suit Resurrected
• Silicon Valley Counsel: Cadence's Smith McKeithen
• Judge Tosses Sandoz' Injunctive Bid Over Zocor
• Sick Of Waiting For Patent Fight, EchoStar Files Suit
• Recent Developments Regarding Permanent Injunctions In Patent Cases
• Sidley Austin Signs On Three Patent Attorneys
• Patent Exhaustion Case Tossed Back To District Court
• Dusa Targets Chemical Supplier, Physicians In Suits
• Vision Companies Settle Patent Dispute
• Medegen Unit Hits ICU Medical With Suit
• FTC Scrutiny Casts Doubt On Plavix Settlement
• Copyright Suit Over Proposed WTC Architecture Settled
• Chemical Cos. Settle Spat Over Cystic Fibrosis Drug
• Forest Sues To Keep Generic Lexapro Off Market
• Sanyo Follows Philips Into License Deal With Acacia
• Klausner Targets Vonage In VoIP Infringement Suit
• Amgen Loses Battle In Anemia War With La Roche
• Congress Wary Of Tax Business Method Patents
• ITC Launches Probe Into Nokia's Phone Technology
• Utah's "Clean Movie" Companies Illegitimate: Judge
• Rival Hits J2 Global With New Antitrust Suit
• Stinging Setback For Inventor In Patent Lawsuit
• Lawsuit Targets Director Of USPTO
• University, Nektar Settle Patent Feud For $25M
• J&J Subsidiaries Fight Back Generic Challenge
• DirecTV Socked With More Damages
• Defendants Cave To Acacia Over Resource Tools
• Silicon Valley Counsel: HP's Jeffrey "Jeff" Fromm
• Pepsi Helps Bust Sellers Of Coke Trade Secrets
• Silicon Valley Counsel: Xilinx's Thomas LaVelle
• Device Makers Settle Suit Over Incontinence Treatment
• Oracle Launches Pre-Emptive Suit Against EpicRealm
• Ruling Sets Up Patent Battle Over Growth Treatment
• Citizen Petitions Come Under Fire In Pharma War
• French "iTunes Law" Threatens IP Rights
• Antitrust Charges Against Qualcomm Piling Up
• Execs Charged With Peddling Trade Secrets
• NetRatings, Unica Settle Patent Feud
• Bank, Tech Co. Settle Over Digital Security Patent
• Silicon Valley Counsel: Rambus' Kent Richardson
• The Gathering Storm: Supreme Court Case Promises Change in Patent Law